Is there a potential role for using Theranos technology for certain blood tests in the evaluation and care of Ebola patients because it does not require venipuncture and requires only very small amounts of blood?
I have no personal experience with the technology and no expertise in this area, but it seems worth looking at by those who have the expertise.
Their website: http://www.theranos.com/
From Wikipedia: "Theranos uses a fingerstick to draw a micro sample of blood into a cartridge, which is loaded into a local reader for analysis. The results are sent wirelessly from the reader to a secure database. The company says that the results are received faster than the usual three-day delay for centralised laboratory testing, up to 30 blood tests can be performed on a single blood sample, and its method ensures accuracy by eliminating or reducing most human handling and delays associated with traditional blood tests."